Congress highlights: DMTR

For congress highlights from Chicago, MEDtalks is the place to be. 

In this on-demand video dr. Karijn Suijkerbuijk, medical oncologist at UMC Utrecht, presents 2 interesting studies from the Dutch Melanoma Treatment Registry (DMTR). 

By watching this video you are immediately up to date with the latest news on DMTR, without having to leave your practice.

Dr. Suijkerbuijk discusses the following topics: 

• Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: Propensity score–matched recurrence-free, distant metastasis-free, and overall survival analysis
• Efficacy of encorafenib/binimetinib in patients with metastatic melanoma with brain metastases: Results from the nationwide Dutch Melanoma Treatment Registry